Beijing Leadman Biochemistry Co Ltd Total Liabilities
Beijing Leadman Biochemistry Co Ltd total liabilities. Based on the latest financial reports, Beijing Leadman Biochemistry Co Ltd (300289) has total liabilities worth CN¥97.10 Million CNY (≈ $14.21 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Beijing Leadman Biochemistry Co Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Beijing Leadman Biochemistry Co Ltd (2008–2025)
Total liabilities of Beijing Leadman Biochemistry Co Ltd from 2008 to 2025. This chart illustrates how Beijing Leadman Biochemistry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 300289 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Beijing Leadman Biochemistry Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beijing Leadman Biochemistry Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TaiMed Biologics
TWO:4147
|
Taiwan | NT$824.49 Million |
|
Kaiser China Holding Co Ltd
SHE:002425
|
China | CN¥419.04 Million |
|
Oceana
JSE:OCE
|
South Africa | ZAC4.09 Billion |
|
Matrix Concepts Holdings Bhd
KLSE:5236
|
Malaysia | RM1.18 Billion |
|
Cerus Corporation
NASDAQ:CERS
|
USA | $154.62 Million |
|
Gresgying Digital Energy Technology Co Ltd
SHG:600212
|
China | CN¥2.09 Billion |
|
Ovid Therapeutics Inc
NASDAQ:OVID
|
USA | $22.08 Million |
|
Hunan Airbluer Environmental Protection Technology Co. Ltd.
SHE:301259
|
China | CN¥611.23 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Beijing Leadman Biochemistry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Beijing Leadman Biochemistry Co Ltd's balance sheet.
Liquidity & Leverage Metrics
Beijing Leadman Biochemistry Co Ltd Total Liabilities Ratios Explained
Beijing Leadman Biochemistry Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.99 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Leadman Biochemistry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Leadman Biochemistry Co Ltd (2008–2025)
The table below shows the annual total liabilities of Beijing Leadman Biochemistry Co Ltd from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥105.46 Million ≈ $15.43 Million |
+1.56% |
| 2024-12-31 | CN¥103.84 Million ≈ $15.19 Million |
-22.37% |
| 2023-12-31 | CN¥133.77 Million ≈ $19.57 Million |
-38.26% |
| 2022-12-31 | CN¥216.67 Million ≈ $31.71 Million |
-41.49% |
| 2021-12-31 | CN¥370.30 Million ≈ $54.19 Million |
+48.17% |
| 2020-12-31 | CN¥249.92 Million ≈ $36.57 Million |
-5.39% |
| 2019-12-31 | CN¥264.18 Million ≈ $38.66 Million |
-9.47% |
| 2018-12-31 | CN¥291.80 Million ≈ $42.70 Million |
-11.23% |
| 2017-12-31 | CN¥328.73 Million ≈ $48.10 Million |
+0.80% |
| 2016-12-31 | CN¥326.13 Million ≈ $47.72 Million |
-18.21% |
| 2015-12-31 | CN¥398.76 Million ≈ $58.35 Million |
-23.82% |
| 2014-12-31 | CN¥523.48 Million ≈ $76.60 Million |
+33.25% |
| 2013-12-31 | CN¥392.86 Million ≈ $57.49 Million |
+6.42% |
| 2012-12-31 | CN¥369.17 Million ≈ $54.02 Million |
+154.80% |
| 2011-12-31 | CN¥144.89 Million ≈ $21.20 Million |
+46.36% |
| 2010-12-31 | CN¥98.99 Million ≈ $14.49 Million |
+107.62% |
| 2009-12-31 | CN¥47.68 Million ≈ $6.98 Million |
+58.91% |
| 2008-12-31 | CN¥30.01 Million ≈ $4.39 Million |
-- |
About Beijing Leadman Biochemistry Co Ltd
Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People's Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnolo… Read more